Clinical Trial

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphedema) in patients undergoing a hysterectomy for stage I endometrial cancer. Standard lymph node dissection removes lymph nodes around the uterus during a hysterectomy to look for spread of cancer from the uterus to nearby lymph nodes. Sentinel lymph node mapping uses a special dye and camera to look for cancer that may have spread to nearby lymph nodes. Comparing the results of the procedures may help doctors predict the risk of long-term swelling in the legs.
Protocol Amendment History 1 change
notable Trial sites expanded: 55 -> 60 locations 2026-08-08
Trial Details
NCT Number NCT05646316
Lead Sponsor NRG Oncology
Collaborators: National Cancer Institute (NCI)
Conditions Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Enrollment 428 participants
Start Date 2022-12-07
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-07